Susquehanna Portfolio Strategies, LLC
Position in DGX — Quest Diagnostics Inc
CIK 1996449
Bala Cynwyd, PA
Position in DGX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$12,802,627
+$6,336,659 QoQ
Shares Held
60,404
+83.1% QoQ
Ownership
0.055%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#154
of 1,096 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DGX Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Susquehanna Portfolio Strategies, LLC holds $90,460,548 across 7 Diagnostics & Research names. DGX ranks #3 (14.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | A |
Agilent Technologies, Inc.
|
350,725 | $46,586,801 | |
| 2 | GH |
Guardant Health, Inc.
|
155,346 | $23,306,560 | |
| 3 | DGX |
Quest Diagnostics Inc
This page
|
60,404 | $12,802,627 | |
| 4 | GRAL |
GRAIL, Inc.
|
71,088 | $4,853,177 | |
| 5 | PSNL |
Personalis, Inc.
|
121,299 | $1,625,406 | |
| 6 | CDNA |
CareDx, Inc.
|
45,122 | $1,285,977 | |
| 7 | ADPT |
Adaptive Biotechnologies Corp
|
54,788 | $0 |
All Filings in DGX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,802,627 | 60,404 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $6,465,968 | 32,993 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $6,320,136 | 36,421 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||